Overview
AKASA develops AI for complex healthcare revenue-cycle work, including inpatient coding.
What AKASA does
AKASA builds AI for healthcare revenue-cycle operations, with its current platform emphasizing inpatient coding and clinical documentation improvement. It reads the patient record and applies a health system’s documentation patterns, case mix and coding standards to support accurate reimbursement.
Autonomous Coding produces codes with supporting evidence, subject to the organization’s quality thresholds. The Prebill Optimization Suite combines Coding Optimizer and CDI Optimizer to identify missed opportunities, documentation gaps and compliance risks before billing.
AI Advisor helps revenue-cycle staff find answers and source material, while Auth Status and Claim Status automate administrative follow-up. AKASA’s implementation adapts to the individual health system rather than treating every provider’s rules and clinical documentation as interchangeable.
Company details
- Funding
- $60 million Series B (March 2021)
Founders & leadership
Investors & backers
AKASA announced a $60M Series B led by BOND on March 23, 2021.
- BOND
Andreessen Horowitz- Costanoa Ventures









